Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Uterine Cervical Neoplasms

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Uterine Cervical Neoplasms in 4 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.

Research Excerpts

ExcerptRelevanceReference
"The U14 cervical cancer cells were injected in C57BL/6 mice to induce tumor-bearing condition."1.42[Production and mechanism of CCL5 by macrophages in U14 cervical cancer-bearing mice during infection]. ( Fan, X; Li, X; Ren, G; Ren, H; Sun, L; Wang, Y, 2015)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Anoopkumar-Dukie, S1
Conere, T1
Houston, A1
King, L1
Christie, D1
McDermott, C1
Allshire, A1
Ren, H1
Ren, G1
Sun, L1
Fan, X1
Wang, Y1
Li, X1
Eichele, K1
Ramer, R1
Hinz, B1
Han, S1
Inoue, H1
Flowers, LC1
Sidell, N1

Other Studies

4 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Uterine Cervical Neoplasms

ArticleYear
The COX-2 inhibitor NS398 selectively sensitizes hypoxic HeLa cells to ionising radiation by mechanisms both dependent and independent of COX-2.
    Prostaglandins & other lipid mediators, 2020, Volume: 148

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Survival; Cyclooxygenase 2; Female; HeLa Ce

2020
[Production and mechanism of CCL5 by macrophages in U14 cervical cancer-bearing mice during infection].
    Zhonghua fu chan ke za zhi, 2015, Volume: 50, Issue:5

    Topics: Animals; Chemokine CCL5; Culture Media, Conditioned; Cyclic AMP; Cyclooxygenase 2; Dinoprostone; Enz

2015
R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway.
    Pharmaceutical research, 2009, Volume: 26, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Arachidonic Acids; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors;

2009
Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Oct-01, Volume: 9, Issue:12

    Topics: Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxy

2003